Viewpoint Molecular Targeting Announces Appointment of Markus Puhlmann, MD, MBA as Chief Medical Officer.
Click here for the details
Cesium 131 is a proven, minimally invasive treatment designed to treat a variety of cancers with precision.
A diagnosis is the first step towards treating your cancer.
With the many advances and options in cancer treatment, determining what is right for you can feel overwhelming.
Isoray is here to help.
We’re committed to providing a powerful, proven treatment while connecting you with the very best care teams available.
Patients & Families
Find a Doctor Near You
A diagnosis is just the first step toward treating your cancer. We are here to help you make an informedtreatment decision with your doctor so you can begin living your life again.
Years of Data
Patients Treated
Day Half Life
Treats cancer at the source
Higher energy, greater coverage
Shorter half-life for rapid resolution of side-effects
Quick recovery time for most patients
“Cesium-131 provides everything we want for prostate brachytherapy as both a monotherapy and in combination therapy, including delivery of a high dose of radiation more quickly for high risk patients in a low dose rate ‘setting.’”
About Us
Isoray develops innovative, personalized brachytherapy products that effectively treat many forms of cancer.
Blog
It’s More Than Just One Month
By CEO Lori Woods Prostate Cancer Awareness Month carries more than the obvious meaning. Of course, its intent is to raise awareness in hopes that we will motivate more men to get screened because we know all too well how that can impact lives. For...
Press Releases
Isoray Announces Transformational Merger and Fourth Quarter and Full-Year Fiscal Year End 2022 Financial Results
RICHLAND, WASHINGTON – September 28, 2022 – Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced that it has entered into a definitive agreement to acquire Viewpoint Molecular...
News
South Florida Hospital News & Healthcare Report with Chief Research & Development Officer Bill Cavanagh and prominent doctors on treating cancers with Cesium-131
To read the full article below, please use the navigation arrows at the bottom of each page which become visible when you place your cursor at the bottom of each page....
Whether you’re a Patient or a Clinician,
we’re here to help.
Call us at 1-509-375-5329